North Shore Equity Rotation ETF (KOOL)
| Assets | $53.77M |
| Expense Ratio | 0.94% |
| PE Ratio | 32.24 |
| Shares Out | 4.04M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 1,984 |
| Open | 13.36 |
| Previous Close | 13.34 |
| Day's Range | 13.29 - 13.36 |
| 52-Week Low | 8.95 |
| 52-Week High | 13.62 |
| Beta | n/a |
| Holdings | 42 |
| Inception Date | Apr 1, 2024 |
About KOOL
Fund Home PageThe North Shore Equity Rotation ETF (KOOL) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, aiming to outperform the S&P 500 index by investing globally in stocks of any market capitalization. Investments are adjusted towards sectors the funds adviser identifies as possessing the greatest performance potential. KOOL was launched on Apr 1, 2024 and is issued by North Shore.
Top 10 Holdings
43.83% of assets| Name | Symbol | Weight |
|---|---|---|
| iShares Core S&P 500 ETF | IVV | 7.10% |
| NVIDIA Corporation | NVDA | 5.30% |
| Quanta Services, Inc. | PWR | 4.44% |
| State Street Health Care Select Sector SPDR ETF | XLV | 4.26% |
| Amazon.com, Inc. | AMZN | 4.06% |
| iShares MSCI EAFE ETF | EFA | 4.05% |
| Apple Inc. | AAPL | 3.75% |
| Cameco Corporation | CCJ | 3.63% |
| State Street Technology Select Sector SPDR ETF | XLK | 3.62% |
| Kinder Morgan, Inc. | KMI | 3.61% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2024 | $0.0228 | Dec 31, 2024 |
| Sep 27, 2024 | $0.01385 | Sep 30, 2024 |
| Jun 28, 2024 | $0.0245 | Jul 1, 2024 |
Performance
KOOL had a total return of 31.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.81%.
News
CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies
New York City, NY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you have been trying to lose weight but nothing seems to work anymore, you are not alone. Many people feel stuck. They eat better. They try to m...
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
AURORA, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Losing weight can often feel like an uphill battle, with conflicting advice and complicated diets making the process overwhelming. However, a simple y...
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
AURORA, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Ice Water Hack stands at the core of a rapidly rising weight-loss phenomenon that, according to Dr. Blaine—a leading advocate of metabolic research—rev...
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Off...
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools an...
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell...
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript
Thermogenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - C...
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ...
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
RANCHO CORDOVA, Calif. , July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cau...
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
Conference Call to be Held on May 15, 2023 RANCHO CORDOVA, Calif. , May 10, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ser...
ThermoGenesis Holdings, Inc. (THMO) Q4 2022 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff C...
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
Conference Call to be Held on March 30, 2023 RANCHO CORDOVA, Calif. , March 28, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point...
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
RANCHO CORDOVA, Calif. , March 20, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
RANCHO CORDOVA, Calif. , March 16, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies
RANCHO CORDOVA, Calif. , March 15, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement
RANCHO CORDOVA, Calif. , Jan. 11, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
ThermoGenesis Announces 1-for-45 Reverse Stock Split
RANCHO CORDOVA, Calif. , Dec. 21, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer...
ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update
Conference Call to be Held on November 10, 2022 RANCHO CORDOVA, Calif. , Nov. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and poi...
THERMOGENESIS CLOSES $2.05 MILLION PUBLIC OFFERING
RANCHO CORDOVA, Calif. , Oct. 28, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
THERMOGENESIS PRICES $2.05 MILLION PUBLIC OFFERING
RANCHO CORDOVA, Calif. , Oct. 25, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference
RANCHO CORDOVA, Calif. , Sept. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q2 2022 Results - Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2022 Results Conference Call August 11, 2022 3:00 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Je...
ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update
Driven by Sales of the AXP, Total Revenues for the Quarter Rose 38% Compared to Prior Year Conference Call to be Held Today at 12:00 p.m. PT/3:00 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update
Conference Call to be Held on August 11, 2022 RANCHO CORDOVA, Calif. , Aug. 9, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and...
ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2022 Results - Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q1 2022 Earnings Conference Call May 19, 2022 4:30 AM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cau...
ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide a Corporate Strategic Update
Conference Call to be Held on May 19, 2022 RANCHO CORDOVA, Calif. , May 18, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and se...
Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript
Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript
ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update
Company Signs License Agreement With Boyalife Genomics and will Form TG Biosynthesis Division to Operate as CDMO for Cell and Cell-Based Gene Therapies Leases 35,475 SF To Be Built-Out as cGMP Complia...
ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2021 and Provide a Corporate Strategic Update
Conference Call to be Held on March 28, 2022 RANCHO CORDOVA, Calif. , March 23, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools an...
ThermoGenesis Holdings to Hold Reconvened Annual Meeting of Stockholders on January 13, 2022
RANCHO CORDOVA, Calif., Jan. 11, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), today announced that the Company's 2021 Annual Meeting of Stockholders (the "Annual Meeting") will re...
ThermoGenesis Holdings to Present at the H.C. Wainwright BioConnect Virtual Conference
RANCHO CORDOVA, Calif., Jan. 10, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, t...
ThermoGenesis Holdings Announces Adjournment of Annual Meeting of Stockholders
RANCHO CORDOVA, Calif., Dec. 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), announced that the Company's Annual Meeting of Stockholders (the "Annual Meeting") scheduled for Thur...
Recap: ThermoGenesis Holdings Q3 Earnings
ThermoGenesis Holdings (NASDAQ:THMO) reported its Q3 earnings results on Friday, November 12, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript
Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript
ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update
RANCHO CORDOVA, Calif., Nov. 12, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, t...
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update
RANCHO CORDOVA, Calif., Nov. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...
ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies
RANCHO CORDOVA, Calif., Sept. 14, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
RANCHO CORDOVA, Calif., Sept. 7, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, to...
Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript
Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript
Recap: ThermoGenesis Holdings Q2 Earnings
Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased 2.7% after the company reported Q2 results. Quarterly Results Earnings per share rose 62.75% over the past year to ($0.38), which missed the es...